Overview
Phone
+82 2-3010-4191
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 14, 2023 | Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease | PANGYO, South Korea, Sept. 14, 2023 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application of ADEL-Y01 for the treatment of Alzheimer'... |
| ADEL | “We dream of a world without dementia. Alzhheimer's Disease Experts Lab, ADEL,Inc.” |
Reviews 0
FAQ about ADEL, Inc.
What has the press written about ADEL, Inc.?
Parsers VC has collected 3 articles mentioning ADEL, Inc., among them “Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease” (Sep 14, 2023) and “ADEL”.
Is ADEL, Inc. still active?
ADEL, Inc. is probably closed: its latest activity on Parsers VC dates from Apr 9, 2026.